Sequenom Inc (SQNM) 1.10 $SQNM Sequenom Files Patent

New Post Public Reply Private Reply Replies (0) Message Board

Jun 12, 2016 at 10:05 AM

Sequenom Inc (SQNM) 1.10 $SQNM

Sequenom Files Patent Infringement Lawsuit in Australia
PR Newswire - Tue Jun 07, 7:30AM CDT
Sequenom, Inc., (NASDAQ: SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, today announced that it filed a patent infringement lawsuit in Australia. The patent relates to the detection of cell-free fetal DNA for non-invasive prenatal testing (NIPT).
SQNM: 1.10 (+0.01)

Sequenom to Present at Jefferies Global Healthcare Conference
PR Newswire - Thu Jun 02, 1:37PM CDT
Sequenom, Inc. (NASDAQ: SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, today announced the Company's participation at the Jefferies 2016 Global Healthcare Conference in New York, NY on June 10, 2016.
SQNM: 1.10 (+0.01)

AWS Morning Technical Breakdown Highlights: bluebird bio, Nektar Therapeutics, Sequenom, and Tesaro
ACCESSWIRE - Mon May 23, 8:18AM CDT
LONDON, UK / ACCESSWIRE / May 23, 2016 / ActiveWallSt.com announces the list of stocks featured in the Technical Morning Blog. Every morning the Active Wall St. team discusses the latest news and technical events impacting stocks and the financial markets. Companies recently featured in the blog include bluebird bio, Nektar Therapeutics, Sequenom, and Tesaro.
BLUE: 41.59 (-3.92), SQNM: 1.10 (+0.01), TSRO: 40.34 (-1.48), NKTR: 15.80 (-0.48)

Sequenom, Inc. Reports First Quarter 2016 Results
PR Newswire - Wed May 04, 3:03PM CDT
Sequenom, Inc. (NASDAQ: SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, today reported total revenues of $27.6 million, total accessioned units of 46,400, and a net loss of $13.4 million, or $0.11 per basic and diluted share, for the first quarter of 2016.
SQNM: 1.10 (+0.01)

Sequenom Announces In-Network Contracts with Anthem Blue Cross and Blue Shield Plans for Georgia, Indiana, Kentucky, Missouri, Ohio, Virginia and Wisconsin
PR Newswire - Tue May 03, 6:01PM CDT
Sequenom, Inc., (NASDAQ: SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, today announced that it has entered into agreements with Blue Cross and Blue Shield of Georgia, Inc. (effective 4/11/16), Anthem Blue Cross and Blue Shield Health Plans for Indiana, Kentucky, Missouri, Ohio and Wisconsin (effective 5/15), and Anthem Blue Cross and Blue Shield in Virginia (effective 5/23/16).
SQNM: 1.10 (+0.01)

Sequenom Completes Consolidation of North Carolina Operations
PR Newswire - Tue Apr 19, 3:02PM CDT
Sequenom, Inc., (NASDAQ: SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, today announced the completion of the previously-announced consolidation of Sequenom Laboratories(TM) North Carolina operations into its San Diego laboratory facility.
SQNM: 1.10 (+0.01)

Sequenom Strengthens Executive Team with New Vice President of Sales
PR Newswire - Tue Apr 12, 3:03PM CDT
Sequenom, Inc. (NASDAQ: SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, is pleased to announce that Glenn Magnuson has joined the Company as Vice President of Sales, reporting to Rob Lozuk, Senior Vice President, Commercial Operations. Mr. Magnuson has more than 25 years of experience in implementing effective sales processes, strategically managing accounts and realizing the revenue potential of medical diagnostic devices.
SQNM: 1.10 (+0.01)

Sequenom Announces In-Network Contracts with Anthem Blue Cross and Blue Shield Plans for Connecticut, Maine, and New Hampshire
PR Newswire - Wed Mar 23, 6:45AM CDT
Sequenom, Inc., (NASDAQ: SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, today announced that its wholly owned subsidiary, Sequenom Laboratories(TM), has entered into agreements with Anthem Blue Cross and Blue Shield Health Plans for the states of Connecticut, Maine, and New Hampshire, effective March 28, 2016.
SQNM: 1.10 (+0.01)

Sequenom Files Petition With the Supreme Court of the United States Requesting Review Of Decision On '540 Patent
PR Newswire - Mon Mar 21, 3:05PM CDT
Sequenom, Inc. (NASDAQ: SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, announced that it filed a petition today with the Supreme Court of the United States to review decisions by lower Federal courts that the claims of Sequenom's U.S. Patent No. 6,258,540 ("'540 Patent"

are not patent eligible under the patent eligibility criteria established by the Supreme Court's Mayo Collaborative Services v. Prometheus Laboratories decision. In the petition, Sequenom urges the Court to hear the case because the Court is uniquely suited to reconcile and interpret the patent eligibility criteria established in its Mayo decision. Those overly-expansive patent eligibility criteria have not only negatively impacted Sequenom's patent, but have put into jeopardy the patentability of existing and future diagnostic method patent claims.
SQNM: 1.10 (+0.01), RXDX: 5.79 (-0.22)

Four Biotechs To Consider On Intermediate Bottom, Trend Change Signal
ACCESSWIRE - Mon Mar 14, 9:10AM CDT
NEW YORK, NY / ACCESSWIRE / March 14, 2016 / 2015 was a wild year in biotech, with six months of sector-wide gains during January to July reversed throughout the latter half of the year on a combination of political reform expectations and US rate-hike-induced risk-off sentiment. We're nearly a full quarter into 2016, and it looks like we may have finally seen an intermediate bottom in stocks with yesterday's big up move holding today, March 2.
SQNM: 1.10 (+0.01), CDTX: 10.42 (-0.18), ATHX: 2.38 (+0.03)

Sequenom Announces Contract with Anthem BlueCross
PR Newswire - Wed Mar 02, 3:39PM CST
Sequenom, Inc., (NASDAQ: SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, announced the completion of an agreement with Anthem BlueCross. The agreement provides in-network coverage for Anthem's California customers for Sequenom Laboratories' noninvasive prenatal tests in both high and average risk pregnancies, beginning March 1, 2016.
SQNM: 1.10 (+0.01)

Sequenom reports 4Q loss
Automated Insights - Wed Mar 02, 3:17PM CST
SAN DIEGO (AP) _ Sequenom Inc. (SQNM) on Wednesday reported a fourth-quarter loss of $12.2 million, after reporting a profit in the same period a year earlier.
SQNM: 1.10 (+0.01)

Sequenom, Inc. Reports 2015 Financial Results
PR Newswire - Wed Mar 02, 3:05PM CST
Sequenom, Inc. (NASDAQ: SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, today reported results for the fourth quarter and full year 2015.
SQNM: 1.10 (+0.01)

Can The Uptrend Continue for Sequenom (SQNM)?
Zacks Equity Research - Zacks Investment Research - Fri Feb 05, 7:24AM CST
Investors certainly have to be happy with Sequenom Inc. (SQNM) and its short term performance
SQNM: 1.10 (+0.01)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ortho Molecular and HANS: Streamlining Functional Medicine

Functional Medicine Gets a Tech Boost The world of functional medicine just got a major shot in the arm, courtesy of an intriguing alliance between Ortho Molecular Products and HANS.FM. First of all, let's address the elephant in the room: clinicians in this field aren't exactly on a coffee break. They’re buried under mountains of paperwork, often spending hours just...

CURE Intl and Thoughtworks Step Into Digital Era

Pushing Paper Out, Digitizing In In a world where tech is king, why were hospitals—crucial, life-saving institutions—still bogged down by dusty folders and ink smudges? Well, not anymore for CURE International, not with Thoughtworks stepping up to the plate. This ain't just swapping paper for pixels; it's a lifeline for kids getting world-class surgical care without...

Jinko Solar Joins B20 Summit: Energy Forefront Focus

Jinko Solar's Invitation to the B20 Summit Never a dull moment in the solar space, especially when Jinko Solar, a big shot in clean energy, jumps into the spotlight at the B20 Summit in the U.S. Awash with high-profile discussions, Jinko's not just chatting—it's the only photovoltaic firm strutting its stuff in D.C. with gutsy calls for energy reform. Key Takeaways from...

Jubilant Eyes MPN Breakthrough with JBI-802 Data at ASH

Presenting the Case for JBI-802 From the bustling circus of drug development, here comes Jubilant Therapeutics, strutting their stuff with JBI-802, a dual inhibitor designed to tackle myeloproliferative neoplasms (MPNs) with a one-two punch. Now, they're set to drop some spicy deets at the 68th ASH Annual Meeting in New Orleans this December. So what's the fuss about?...

Agilyx's Q3 Update: GreenDot Shines Amid Mixed Results

Peeking into Agilyx's Financial Odyssey Just as I sip my morning coffee pondering the highs and lows of the market, here comes Agilyx ASA splashing some liquidity on the scene. The Q3 report paints the company in various shades—from solid greens to hesitant reds. Nothing like the thrill of untangling mixed results over a quiet day, huh? GreenDot's Climb to Profitability...

Inflatable Wonders Turn Christmas into a Hoot at Lowe's

Inflatables Bringing the Cheer (and Laughs) Well, it's that season again—where decorations either have us grumbling at the electric bill or chuckling at the lawn art. Lowe's has teamed up with Gemmy to serve a heaping platter of holiday giggles this year. They've rolled out a quirky lineup of inflatables that go from shivering Highland cows to dinosaurs and elves....

LG Innotek Scores Hat Trick with CES Innovation Wins

LG Innotek's Lighting Triumph Here we go again, LG Innotek just snagged their third CES Innovation Award in a row, this time for their cutting-edge vehicle lighting module, Nexlide C+. It's one for the books—breaking into the 2027 CES spotlight with innovative tech that not only grabs the eyes but could also steal the hearts of investors willing to bet on the future of...

RF MEDICAL Expands into Europe with New CE Certification

RF MEDICAL Secures CE Marking for Mi-BLATOR™ Just when you think the European medical device market's hit its saturation point, RF MEDICAL decides to kick the door open with their Mi-BLATOR™ microwave ablation system. This ain't just another plastic gadget, folks; it's got that shiny new CE marking under the European Union's Medical Device Regulation (MDR). Now, what...

BD Sets Stage for Investor Day in December 2026

BD's Investor Day: A Peek into the Future Say what you will about investor meets, but BD (Becton, Dickinson and Company) throwing its shindig on December 10, 2026, could be a highlight on the calendar if you're eyeing the medical technology sector. Scheduled in New York, this event is gearing up to be a canvas for BD's higher-ups to sketch out their roadmap. If you’re...

Centrus Energy Welcomes Nuclear Veteran to Leadership

Navigating a New Era at Centrus When you hear about seasoned veterans stepping up to the plate in the energy sector, it's time to perk up your ears. Centrus Energy (NYSE:LEU), a big player in nuclear fuel, just added Kevin Graney to their Board of Directors. This isn't your run-of-the-mill appointment; it packs nearly three decades of nuclear tech and national security...